Skip to content

TO access the effect of two Vamana Kalpa in Acne Vulgaris

A comparative clinical trial to evaluate the efficacy of Vamana Karma with two Madanaphala Kalpa in Mukhadushika with special emphasis on Acne Vulgaris. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085931
Enrollment
40
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

Dr Anuja Daga
Lead Sponsor
Ayurveda mahavidyalaya Hubli
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1Subjects presenting with Signs and Symptoms of Mukhadushika (Acne Vulgaris). 2 Subjects of age group between 16-36 years irrespective of gender will be included. 3 Subject with controlled Diabetes (HbA1C up to 8) and Hypertension (140/90 mm of Hg). 4 Subjects fit for Vamana Karma

Exclusion criteria

Exclusion criteria: 1 Subject with Pidika other than face. 2 Subjects with other Kshudra Roga and Kushtha Roga. 3 Pidika due to side effects/allergic reaction of any drug applied earlier. 4 Subjects with co-morbidities and life-threatening disease which interferes intervention. 5 Subjects already received steroid therapy.

Design outcomes

Primary

MeasureTime frame
reduction of acneTimepoint: 3-4 weeks

Secondary

MeasureTime frame
reduction of acne & increased complexionTimepoint: 3 weeks

Countries

India

Contacts

Public ContactDr Anuja Daga

Ayurveda Mahavidyalaya and hospital

padmavatikulkarni203@gmail.com9448235819

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026